MARVEL BIOSCIENCES CORP.

1 record totalling $47,000.00 CAD, from official Government of Canada open data.

Embed this chart

By department

Records

National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program
FY 2025-2026
Canada

MB-204 is a novel therapeutic candidate with the potential to treat pediatric neurodevelopmental disorders, including Autism, Rett syndrome, and Fragile X syndrome. Many of these patients experience s...